Literature DB >> 7016301

Insulin and glucagon secretion by renal adenocarcinoma.

K Pavelić, M Popović.   

Abstract

A patient with histologically verified renal adenocarcinoma had dramatic increases in glucagon and insulin levels in plasma and in tumor tissue.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7016301     DOI： 10.1002/1097-0142(19810701)48:1<98::aid-cncr2820480119>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

2.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.

Authors:  Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Journal:  Rev Urol       Date:  2002

3.  Perioperative Considerations in Metastatic Renal Cell Carcinoma.

Authors:  Kate Flavin; Nikhil Vasdev; Jim Ashead; Tim Lane; Damian Hanbury; Paul Nathan; Shanmugasundaram Gowrie-Mohan
Journal:  Rev Urol       Date:  2016

4.  New onset hyperglycemia attributed to renal cell carcinoma.

Authors:  Jonathan Gapp; Muhammad Fazeel Anwar; Jai Parekh; Timothy Griffin
Journal:  Intractable Rare Dis Res       Date:  2018-05

5.  The role of insulin-related substance in Hodgkin's disease.

Authors:  T Cabrijan; S Levanat; B Pekić; J Pavelić; R Spaventi; H Frahm; V Zjacić-Rotkvić; V Goldoni; D Vrbanec; M Misjak
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

6.  Glucagon-producing mucinous tubular and spindle cell variant of renal cell carcinoma with paraneoplastic diabetes: Case report and review of literature.

Authors:  Ashish Khanna; Sharwan Kumar Singh; Ritambara Nada
Journal:  Indian J Urol       Date:  2021-04-01

7.  Insulin-tumour interrelationship in EL4 lymphoma or thymoma-bearing mice. I. Alloxan-diabetic or non-diabetic mice.

Authors:  D Yam; A Zilberstein; A Fink; I Nir
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

8.  Modulation of insulin/IGFs pathways by sirtuin-7 inhibition in drug-induced chemoreistance.

Authors:  Ahmad Aljada; Ayman M Saleh; Salem Al Suwaidan
Journal:  Diagn Pathol       Date:  2014-05-22       Impact factor: 2.644
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.